Jan 11
|
40 Cities with the Lowest Life Expectancy in the US
|
Oct 30
|
Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil
|
Oct 27
|
Biophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panel
|
Jul 20
|
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
|
Jul 19
|
Biophytis Announces $3.8 Million Registered Direct Offering
|
Jul 18
|
Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound
|